Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab
Abstract
On the basis of a post hoc analysis of data from the T72 clinical trial on the effect of infliximab in pediatric patients with UC, the PUCAI was no less predictive of sustained remission than mucosal healing at week 8, and both were superior to CRP level. Routine endoscopic evaluation in children wi …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
female
male
adolescent
Child
Clinical Trial
Antibodies
Monoclonal / therapeutic use*
Multicenter Study
Colitis
Ulcerative / drug therapy*
c-reactive protein / analysis
infliximab
intestinal mucosa / pathology
immunologic factors / therapeutic use*
pmid:23672831
doi:10.1016/j.cgh.2013.04.049
dan turner
anne m griffiths
jeffrey hyams
ulcerative / pathology*
colon / pathology*
colonoscopy
Access
Citation
ID:
265925
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
265925
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet